Gianpiero D’Amico

ORCID: 0000-0003-1259-5163
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Imaging and Diagnostics
  • Coronary Interventions and Diagnostics
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Valve Diseases and Treatments
  • Acute Myocardial Infarction Research
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac Arrhythmias and Treatments
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiovascular Function and Risk Factors
  • Infective Endocarditis Diagnosis and Management
  • Pain Management and Treatment
  • Renal Diseases and Glomerulopathies
  • Cardiac and Coronary Surgery Techniques
  • Cardiovascular and Diving-Related Complications
  • Renal and Vascular Pathologies
  • Cardiac tumors and thrombi
  • Cardiac Structural Anomalies and Repair
  • Aortic Disease and Treatment Approaches
  • Cardiovascular Syncope and Autonomic Disorders
  • Pediatric Urology and Nephrology Studies
  • Peripheral Artery Disease Management
  • Cardiac electrophysiology and arrhythmias
  • Coronary Artery Anomalies
  • Cardiac pacing and defibrillation studies
  • Systemic Sclerosis and Related Diseases

Ospedale dell' Angelo
2021-2025

St David's Medical Center
2024

IRCCS Ospedale San Raffaele
2024

Istituto Ortopedico Galeazzi
2024

Fondazione Toscana Gabriele Monasterio
2024

Azienda Ospedaliero Universitaria di Sassari
2024

Agaplesion Markus Hospital
2024

Azienda Ospedaliera Ospedale Maggiore
2022

University of Padua
2012-2021

Policlinico Universitario di Catania
2019-2020

The treatment of coronary artery disease (CAD) in patients with severe aortic valve stenosis (AVS) eligible for transcatheter implantation (TAVI) is not supported by clinical evidence, and the role physiology over anatomy as well timing intervention are defined. FAITAVI (ClinicalTrials.gov: NCT03360591) a nationwide prospective, open-label, multicentre, randomised controlled study comparing angiography-guided versus physiology-guided revascularisation strategy combined significant CAD AVS...

10.4244/eij-d-23-00679 article EN EuroIntervention 2024-04-01

Aims:The aim of this study was to investigate the feasibility, safety and efficacy percutaneous closure for prevention thromboembolic events in patients with atrial fibrillation (AF) left appendage (LAA) thrombus. Methods results:The included consecutive AF LAA thrombus who underwent transcatheter occlusion eight high-volume centres.Clinical transoesophageal echocardiography (TEE) follow-up carried out as per each centre's protocol.Twenty-eight were included.The location distal 100%...

10.4244/eij-d-17-00777 article EN EuroIntervention 2018-01-01

Abstract Aims The present analysis from the Functional Assessment in Elderly Myocardial Infarction Patients with Multivessel Disease (FIRE) trial aims to explore significance of pre-admission physical activity and assess whether benefits physiology-guided complete revascularization apply consistently sedentary active older patients. Methods results aged 75 years or more myocardial infarction (MI) multivessel disease were randomized receive culprit-only strategy. primary outcome was a...

10.1093/eurjpc/zwae069 article EN European Journal of Preventive Cardiology 2024-03-07

Data on transcatheter aortic valve replacement (TAVR) long-term clinical outcomes and hemodynamic performance of the self-expandable CoreValve (CV) balloon-expandable Edwards SAPIEN XT (ES) (Edwards Lifesciences, Irvine, California, USA) heart valves (THV) are limited. Therefore, this study aimed to compare outcome data TAVR with either CV or ES.We reviewed prospectively collected 171 patients treated for severe stenosis (AS) at our center between June 2007 December 2010, last follow-up...

10.21037/acs.2017.08.02 article EN Annals of Cardiothoracic Surgery 2017-09-01

The coronary sinus Reducer is a percutaneous device proven to improve angina symptoms in refractory (RA). We evaluated its potential cost-effectiveness and impact on the healthcare resource use. Angina-related usage quality-of-life data were collected for 215 consecutive RA patients undergoing implantation Belgium, Netherlands, Italy. Costs assessed from each country's system perspective. Data date of diagnosis [Standard-of-Care (SoC)-period] follow-up (Reducer-period) compared: during...

10.1093/ehjqcco/qcz027 article EN European Heart Journal - Quality of Care and Clinical Outcomes 2019-05-17

To compare outcomes of patients who underwent left atrial appendage occlusion (LAAO) for nonvalvular fibrillation (NVAF) and contraindication to anticoagulants due history either gastrointestinal (GI) or intracranial (IC) bleeding.Patients with NVAF that LAAO GI IC bleeding from seven centers were included in this observational study. Baseline characteristics, procedural features, follow-up data collected, compared between the two groups. The primary incidence ischemic hemorrhagic events at...

10.1002/ccd.30629 article EN Catheterization and Cardiovascular Interventions 2023-03-15

Tryton side branch (SB) reverse culotte stenting has been employed for the treatment of left main (LM) stem bifurcations in patients at high risk bypass surgery. The aim this study was to assess acute angiographic results and six-month clinical outcome after implantation stent LM.We studied 52 consecutive with LM disease treated nine European centres. Angiographic data analysis performed centrally. Fifty-one (age 68±11 yrs, 75% male, 42% unstable angina, SYNTAX score 20±8) were successfully...

10.4244/eijv8i11a194 article EN EuroIntervention 2013-03-01
Coming Soon ...